Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Glucocorticoid effects on memory retrieval require concurrent noradrenergic activity in the hippocampus and basolateral amygdala
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 969526
Author(s) Roozendaal, Benno; Hahn, Emily L.; Nathan, Sheila V.; de Quervain, Dominique J.-F.; McGaugh, James L.
Author(s) at UniBasel de Quervain, Dominique
Year 2004
Title Glucocorticoid effects on memory retrieval require concurrent noradrenergic activity in the hippocampus and basolateral amygdala
Journal Journal of Neuroscience
Volume 24
Number 37
Pages / Article-Number 8161-9
Abstract Previous findings indicate that administration of abeta-adrenoceptor antagonist systemically blocks glucocorticoid impairment of memory retrieval. Here, we report that beta-adrenoceptor activation in the hippocampus and the basolateral complex of the amygdala (BLA) is implicated in the impairing effects of glucocorticoids on memory retrieval. The specific glucocorticoid receptor (GR) agonist 11beta,17beta-dihydroxy-6,21-dimethyl-17alpha-pregna-4,6-trien-20yn-3-one (RU 28362) (15 ng) infused into the hippocampus of male Sprague Dawley rats 60 min before water maze retention testing, 24 hr after training, impaired probe trial retention performance, as assessed by quadrant search time and initial latency to cross the platform location. Because we found previously that RU 28362 infused into the hippocampus does not affect water maze acquisition or immediate recall, the findings suggest that the GR agonist-induced retention impairment was attributable to a selective influence on long-term memory retrieval. Likewise, systemic injections of the beta1-adrenoceptor partial agonist xamoterol (3.0 or 10.0 mg/kg, s.c.) 60 min before the probe trial dose-dependently impaired retention performance. The beta-adrenoceptor antagonist propranolol (2.0 mg/kg) administered subcutaneously before retention testing did not affect retention performance alone, but blocked the memory retrieval impairment induced by concurrent intrahippocampal infusions of RU 28362. Pretest infusions of the beta1-adrenoceptor antagonist atenolol into either the hippocampus (1.25 microg in 0.5 microl) or the BLA (0.5 microg in 0.2 microl) also prevented the GR agonist-induced memory retrieval impairment. These findings suggest that glucocorticoids impair retrieval of long-term spatial memory by facilitating noradrenergic mechanisms in the hippocampus, and additionally, that norepinephrine-mediated BLA activity is critical in enabling hippocampal glucocorticoid effects on memory retrieval.
Publisher Society for Neuroscience
ISSN/ISBN 0270-6474 ; 1529-2401
edoc-URL http://edoc.unibas.ch/46531/
Full Text on edoc No
Digital Object Identifier DOI 10.1523/JNEUROSCI.2574-04.2004
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/15371517
ISI-Number WOS:000223884400019
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.394 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
03/05/2024